Relay Therapeutics executive sells 753 shares to cover RSU taxes
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Relay Therapeutics Chief Corporate Development Officer Peter Rahmer sold 753 common shares at Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context